Medication Shortage Means Many With Advanced Prostate Cancer Are Missing Treatments
TUESDAY, March 21, 2023 (HealthDay News) — An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment. The drug’s maker, Novartis Pharmaceuticals Corp., has said it can’t keep up with demand for the medication, known as Pluvicto.Continue Reading










